Full-Time
Biotechnology firm specializing in DNA sequencing
$125k - $165k/yr
Senior, Expert
San Diego, CA, USA
Element Biosciences focuses on next-generation sequencing (NGS) technology with its main product, the AVITI System, which offers high-quality sequencing at a low cost of $1 per million reads. This compact benchtop system is designed for various clients, including academic researchers and pharmaceutical companies, providing industry-leading accuracy and cost-effectiveness. The company stands out by forming partnerships with other biotech firms, like QIAGEN, to deliver complete NGS workflows and by offering the 2023 AVITI for All Grant, which provides free sequencing for diverse applications. Element Biosciences aims to make high-quality sequencing accessible to accelerate research in the biotechnology field.
Company Size
201-500
Company Stage
Series D
Total Funding
$678M
Headquarters
San Diego, California
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
100% company-paid medical, dental, & vision coverage
Flexible spending & health savings accounts
Premier mental health care
401(k) with immediately vested 4% company match
Company-paid Life and AD&D insurance
Stock option grants
Flexible time off
10 paid annual holidays
8-weeks paid parental leave
SAN DIEGO, CA (June 5, 2025) - Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced they will be presenting at the annual Human Cell Atlas (HCA) general meeting in Singapore as part of the company's ongoing commercial partnership with the consortium.
Daicel Arbor Biosciences and Element Biosciences launch the 2025 AVITI for Agrigenomics Accelerator Grant.
ANN ARBOR, Mich., April 10, 2025 /PRNewswire/ - Daicel Arbor Biosciences, a company that offers tools and services to accelerate genomics and synthetic biology research, in collaboration with Element Biosciences, a life sciences company democratizing access to advanced biological tools,...
Genome Sequencing Cost CurveFor most of the history of medicine, doctors have been limited to observing symptoms and trying to alleviate them. This has been especially true for non-infectious diseases stemming from dysfunction in the body, including genetic diseases.With the discovery of DNA structure and function, awarded the 1962 Nobel Prize in Medicine , we started to have a better understanding of how the biological system truly works. PCR technology, awarded the 1993 Nobel Prize in Medicine , would open new ways to analyze it.This further expanded when full genomes started to be sequenced. The first human genome was sequenced in 2003 after 13 years of hard work, for a cost of $3B. Quickly, full-genome sequencing started to become cheaper and cheaper. By 2007, it would cost “only” $1M to sequence a full genome
Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the Innovation Roadmap for AVITI24,(TM) the world's first natively paired spatial multiomic solution.